| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.873 | 0.004 | 0.873 | Hypoglycemic | 0.862 0.004 CID_154699611 | ||
| 0.679 | 0.005 | 0.679 | Immunosuppressant | 0.666 0.006 CID_154699611 | ||
| 0.522 | 0.004 | 0.522 | Calcium channel activator | 0.507 0.005 CID_154699611 | ||
| 0.503 | 0.049 | 0.512 | Cyclophilin D inhibitor | 0.512 0.047 CID_154699611 | CID_154699611 | |
| 0.345 | 0.066 | 0.393 | Immunostimulant | 0.393 0.052 CID_154699611 | CID_154699611 | |
| 0.165 | 0.01 | 0.269 | Estrogen agonist | 0.269 0.005 CID_154699611 | CID_154699611 | |
| 0.146 | 0.006 | 0.153 | Neuraminidase inhibitor | 0.153 0.005 CID_154699611 | CID_154699611 | |
| 0.126 | 0.009 | 0.161 | Androgen agonist | 0.161 0.007 CID_154699611 | CID_154699611 | |
| 0.138 | 0.065 | 0.138 | Sodium channel (voltage-gated) blocker | |||
| 0.068 | 0.029 | 0.07 | Heme oxygenase stimulant | 0.07 0.026 CID_154699611 | CID_154699611 | |
| 0.195 | 0.161 | 0.195 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.118 | 0.09 | 0.118 | Calcium channel blocker | |||
| 0.104 | 0.089 | 0.141 | Estrogen antagonist | 0.141 0.027 CID_154699611 | CID_154699611 | |
| 0.179 | 0.205 | 0.215 | Caspase 3 stimulant | 0.215 0.148 CID_154699611 | CID_154699611 | |
| 0.218 | 0.245 | 0.301 | Calcium channel L-type activator | 0.301 0.157 CID_154699611 | CID_154699611 | |
| 0.061 | 0.102 | 0.085 | Estrogen receptor alpha antagonist | 0.085 0.041 CID_154699611 | CID_154699611 | |
| 0.052 | 0.113 | 0.074 | Androgen antagonist | 0.074 0.073 CID_154699611 | CID_154699611 | |
| 0.063 | 0.143 | 0.115 | Estrogen receptor beta antagonist | 0.115 0.038 CID_154699611 | CID_154699611 | |
| 0.069 | 0.173 | 0.099 | DOPA decarboxylase inhibitor | 0.099 0.078 CID_154699611 | CID_154699611 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |